SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending due to increased 2025 revenue guidance driven by strong DefenCath sales and the Melinta portfolio. The community is discussing the raised guidance and potential for further growth, with some expressing excitement about the company's future prospects. Broader discussions include CorMedix's strategic investment in Talphera and potential impacts of upcoming clinical data.

Amazon.com, Inc. is a multinational technology company, which engages in the provision of online retail shopping services. It operates through the following segments: North America, International, and Amazon Web Services (AWS). The North America segment offers retail sale of consumer products, including from sellers, advertising, and subscriptions services through North America-focused online and physical stores. The International segment focuses on retail sale of consumer products, including from sellers, advertising, and subscription services through internationally-focused online stores. The AWS segment is composed of global sales of compute, storage, database, and other services for start-ups, enterprises, government agencies, and academic institutions. The company was founded by Jeffrey P. Bezos in July 1994 and is headquartered in Seattle, WA.

Amazon.com Inc.

Amazon.com Inc

Amazon's stock is trending due to a widespread AWS outage impacting numerous services and applications, sparking concerns about the reliability of centralized infrastructure. The community is discussing the extent of the disruption and its potential financial repercussions, while also questioning Amazon's ability to maintain its competitive edge in cloud computing and AI amid the issues.

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending as investors are closely watching for potential asset sales and a possible foreign partnership, highlighted by a recent Memorandum of Understanding with a major global steel producer. Community discussions revolve around the impact of this MoU and potential buyout scenarios, alongside the company's strategic position in the US steel market. Additionally, tariffs and macro data surrounding the steel and automotive industries remain key talking points for CLF.

Celcuity, Inc. operates as a cellular analysis company. The company discovers new cancer sub-types and commercializing diagnostic tests designed to improve the clinical outcomes of cancer patients treated with targeted therapies. The firm's proprietary CELx diagnostic platform is the commercially ready technology that uses a patient's living tumor cells to identify the specific abnormal cellular process driving a patient's cancer and the targeted therapy that treats it. The company was founded by Brian F. Sullivan and Lance G. Laing in January 2012 and is headquartered in Minneapolis, MN.

Celcuity Inc

CELC is trending due to positive Phase 3 trial data for its breast cancer therapy, gedatolisib, showing a significant reduction in disease progression risk, leading to community excitement and analyst upgrades. The community is discussing the potential for FDA approval, buyout scenarios, and the impact on treatment standards, while also noting the possibility of a near-term offering. However, some caution against shorting and potential overvaluation, recognizing the strong positive data, while others suggest a pullback is imminent.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is trending due to promising data from its PATHFINDER 2 study, highlighting the potential of its Galleri multi-cancer early detection test; the study results pave the way for FDA submission. Community members are discussing the potential for Medicare coverage and revenue growth, especially with support in Congress, and Samsung's commitment to marketing in Asia. The company is also presenting at the Jefferies Global Healthcare Conference on Wednesday.

Rapt Therapeutics, Inc. operates as a clinical stage immunology-based biopharmaceutical company, which engages in the discovery, development, and commercialization of oral small molecule therapies for patients in oncology and inflammatory diseases. The company was founded in 2015 and is headquartered in South San Francisco, CA.

RAPT Therapeutics Inc

RAPT Therapeutics is trending following positive Phase II data, leading to a trading halt and sparking community discussion around a potential 'crazy spike' upon unhalting. Bullish sentiment is further fueled by analyst upgrades and price target increases, with some speculating about a potential retail squeeze. The community is also closely watching for further developments regarding RAPT's next-generation CCR4 antagonist.

Safe Pro Group, Inc. engages in the provision and acquisition of security and protection products. Its products include Artificial Intelligence (AI) and Machine Learning (ML) software technology and photogrammetry analysis tools, bullet and blast resistant personal protection equipment, and aerial managed services and mission-critical uncrewed solutions. The firm operates through the following segments: Safe-PRO USA, Airborne Response, and Safe Pro AI. The company was founded by Daniyel Erdberg on December 15, 2021 and is headquartered in Aventura, FL.

Safe Pro Group Inc

SPAI is trending due to a strategic investment of $14 million, with community members pointing to this as a sign of confidence in the company's AI-based drone technology. Bullish sentiment is fueled by potential breakout setups, high trading volume, and the company's expansion in the Asia-Pacific region. Discussions also highlight Safe Pro Group's collaborations and its role in landmine detection using AI, positioning it as a key player in the defense and security sector.

BioNexus Gene Lab Corp. operates as a holding company, which engages in the sale of chemical raw materials for the manufacture of industrial, medical, appliance, aero, automotive, mechanical, and electronic industries. It is also involved in the development of liquid biopsy tests for the early detection of biomarkers that are linked to diseases. It operates through the BioNexus Malaysia and Chemrex segments. The company was founded by Liew Choong-Chin on May 12, 2017 and is headquartered in Kuala Lumpur, Malaysia.

BioNexus Gene Lab Corp

BioNexus Gene Lab Corp is trending due to a recently announced strategic partnership, sparking excitement among investors. The community is focused on the potential impact of the partnership, especially given the stock's low float and history as a runner. Some traders believe the stock is due for a significant upward move, while others caution about potential dilution and volatility.

NuCana Plc is a clinical stage biopharmaceutical company. It engages in the business of developing a portfolio of new medicines to treat patients with cancer. The company was founded by Hugh Stephen Griffith and Christopher Barry Wood on January 28, 1997 and is headquartered in Edinburgh, the United Kingdom.

NuCana plc - ADR

NuCana plc

NCNA is trending due to encouraging data releases and regulatory approvals regarding their oncology assets, sparking optimism within the community. Bullish investors are actively discussing the potential for significant price appreciation, fueled by the company's compelling early efficacy in chemo-resistant settings. Some traders are drawing comparisons to other low floaters and anticipating a large move, highlighting the upcoming presentation at the ESMO congress.

Omeros Corp. operates as a biopharmaceutical company. The firm engages in the discovery, development, and commercializing of both small-molecule and protein therapeutics for large market. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

OMER is trending due to a recent licensing deal with Novo Nordisk for a potential $2.1 billion, leading to a significant price surge and high trading volume. The community is actively discussing the potential for a short squeeze, the likelihood of FDA approval for Narsoplimab, and speculation around future royalty payments. Some traders express concern about potential retracement and manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Rocket Lab Corporation (RKLB) Falls More Steeply Than Broader Market: What Investors Need to Know

In the most recent trading session, Rocket Lab Corporation (RKLB) closed at $67, indicating a -3.28% shift from the previous trading day.

Rocket Lab (RKLB) stock gained 1.6% in premarket trading on Thursday after Baird initiated coverage of the stock with a bullish view.According to TheFly, the brokerage gave the stock an ‘Outperform’ rating and $83 price target. Baird’s price target implies a 19.8% upside compared to the stock’s previous closing price.Baird analysts reportedly said that the company's position as a reliable space launch provider is "firmly established" through its 94% mission success rate. The brokerage noted that the 34% compound annual growth rate for revenue through 2030, as projected by consensus, is supported by the larger Neutron rocket.The brokerage stated that the development will enable the company to enter the "highly lucrative" medium-lift market, directly competing with SpaceX's Falcon 9 rocket. Earlier this week, Morgan Stanley analysts labeled Rocket Lab as "an earlier-stage alternative to SpaceX," while noting that the firm's new valuation "takes cues" from SpaceX's implied value.The Neutron rocket is being designed to be more powerful than its Electron rocket, with its first launch targeted for late 2025 or early 2026 from a new dedicated launchpad at Wallops Island, Virginia.Retail sentiment on Stocktwits about <a href="https://stocktwits.com/symbol/RKLB">Rocket Lab</a> was in the 'bullish' territory at the time of writing.<figure class="image"><img style="aspect-ratio:797/102;" src="https://news.stocktwits-cdn.com/RKLB_oct_16_JPG_1148dcd035.webp" alt="RKLB- oct 16.JPG" width="797" height="102"><figcaption>RKLB’s Sentiment Meter and Message Volume as of 05:27 a.m. ET on Oct. 16, 2025 | Source: Stocktwits</figcaption></figure>Last week, Rocket Lab <a href="https://stocktwits.com/news-articles/markets/equity/why-is-rocket-lab-stock-rising-today/ch6aUsXR3S8">secured two</a> dedicated launch agreements with the Japan Aerospace Exploration Agency (JAXA). The missions, both set to launch from Rocket Lab’s New Zealand-based Launch Complex 1, will support JAXA’s Satellite Technology Demonstration Program. The company also signed a multi-launch deal with the Institute for Q-shu Pioneers of Space.Rocket Lab stock has more than doubled this year.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-is-american-battery-technology-stock-crashing-over-20-premarket-today/ch6YySER3Vz">Why Is American Battery Technology Stock Crashing Over 20% Premarket Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, the Rocket Lab logo is seen displayed on a smartphone screen.

Why Is Rocket Lab Stock Gaining Premarket Today? 

Baird said the development of the firm’s Neutron rocket will help the company enter the "highly lucrative" medium-lift market as a direct competitor to SpaceX's Falcon 9.

Equity

KTOS Stock Rises 280.4% in a Year: Buy, Sell or Stay Invested?

Kratos Defense stock surges 280% in a year, fueled by new missile systems, UAV innovations, and strong defense partnerships, but valuation may temper fresh buys.

Rocket Lab Strengthens Ties With Japan: Should You Buy The Stock?

RKLB expands in Japan with JAXA, iQPS and Synspective deals, boosting its launch pipeline but facing high costs and a premium valuation.

SpaceX on Monday carried out a largely successful test flight of its giant Starship rocket from Texas as the Elon Musk-headed company gears up to take astronauts to the moon in a few years.Starship’s eleventh test flight lifted off from the company’s Starbase launch site, 20 miles (32 km) east of Brownsville, at around 7.23 p.m. ET. This was the final flight of the second-generation Starship and the first-generation Super Heavy booster before the company moves on to its upgraded version of the rocket.On Monday, in less than 10 minutes after the launch, the booster separated from the starship, ignited its engines, and then hovered over the water before a controlled splashdown. The mission was mostly similar to the last successful test flight in August, with the Starship deploying mock Starlink satellites and relighting a Raptor engine, demonstrating a critical capability for future deorbit burns.The Starship then re-entered the Earth’s atmosphere, moved toward the Indian Ocean, before successfully executing a landing flip, landing burn, and soft splashdown. It erupted into a fireball after that amid the company’s efforts to test its heat shields.“Great work,” Musk <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://x.com/elonmusk/status/1977917285638754777">said </a>on X in a post. The launch also earned praise from active NASA administrator Sean Duffy, who said the mission was "another major step toward landing Americans on the Moon’s south pole."After costly failures earlier this year, Monday’s successful launch is likely to silence many critics who have raised concerns over the company’s ability to carry NASA astronauts to the moon in 2027 for now. The U.S. aims to return astronauts to the moon for the first time since 1972, as it seeks to compete with China, which has its own plans to send humans there by 2030.However, before it takes off with astronauts, Starship needs to carry out several upgrades, including changes to its docking adapters to perform orbital refueling, which involves two Starships docking in orbit to transfer tons of rocket propellant. The company was expected to test the upgrade this year.“It is highly unlikely that we will land on the moon before China,” Jim Bridenstine, a former NASA administrator, said during a Senate hearing in September, as per a Bloomberg News report, citing the complexity of Starship as one of the main reasons.Retail sentiment on Stocktwits about SpaceX’s rival <a href="https://stocktwits.com/symbol/RKLB">Rocket Lab</a> was in the ‘bullish’ territory at the time of writing.Also See: <a href="https://stocktwits.com/news-articles/markets/equity/why-did-momentus-stock-surge-over-16-after-hours-today/ch6mJsbR3l9">Why Did Momentus Stock Surge Over 16% After-Hours Today?</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

SpaceX Starship rocket takes off during it's sixth test flight on November 19, 2024 in Brownsville, Texas. 

‘Great Work’: Elon Musk Hails SpaceX Starship Success As Moon Mission Draws Close

 Starship’s eleventh test flight lifted off from the company’s Starbase launch site, 20 miles (32 km) east of Brownsville, at around 7.23 p.m. ET.

Rocket Lab Corp. (RKLB) shares soared 5% in Monday morning’s trade after Morgan Stanley raised its price target for the company.According to TheFly, Morgan Stanley expressed optimism about Rocket Lab’s upcoming medium-class launcher, Neutron, nearing its entry into service. The firm raised its price target on the stock to $68 from $20, implying an upside of nearly 6% from the closing price of the shares on Friday.The firm noted that the Neutron program’s initial launch is the next major driver for the Rocket Lab stock.Retail sentiment on Stocktwits around&nbsp;<a href="https://stocktwits.com/symbol/RKLB">Rocket Lab</a> trended in the ‘bullish’ territory at the time of writing.In its note, Morgan Stanley called Rocket Lab an “earlier-stage alternative” to Elon Musk’s SpaceX, while adding that the company’s new valuation “takes cues” from SpaceX’s implied value. The firm maintained its ‘Equal Weight’ rating on the stock, while adding that after Rocket Lab’s surge in 2025 so far, “much appears priced in” at the current valuation.Last week, Rocket Lab&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-rocket-lab-stock-rising-today/ch6aUsXR3S8">secured</a> two dedicated launch agreements with the Japan Aerospace Exploration Agency (JAXA). The missions, both set to launch from Rocket Lab’s New Zealand-based Launch Complex 1, will support JAXA’s Satellite Technology Demonstration Program.The first launch, expected to occur in December 2025, will carry the agency’s RAISE-4 satellite into orbit to showcase eight experimental technologies from a mix of Japanese academic institutions and private-sector firms. The second launch is slated for 2026 and will carry a collection of eight payloads, including educational satellites, an ocean-monitoring system, and a technology demonstration of an origami-inspired deployable antenna capable of expanding 25-fold once in space.The company also&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-rocket-lab-stock-gaining-3-premarket/ch6EffaR3Lm">signed</a> a multi-launch deal with the Institute for Q-shu Pioneers of Space.<a href="https://stocktwits.com/symbol/RKLB">RKLB stock</a> is up 161% year-to-date and 586% in the last 12 months.Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/bloom-energy-shares-soar-5-billion-brookfield-fuel-cells-ai-data-centers/ch6SKLAR3k0">Bloom Energy Shares Soar On $5 Billion Brookfield Deal To Deploy Its Fuel Cells To Power AI Data Centers</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

 In this photo illustration, a person holds a smartphone displaying the logo of Rocket Lab USA Inc.

Why Is Rocket Lab Stock Soaring Today?

Analysts at Morgan Stanley expressed optimism about the initial launch of Rocket Lab’s Neutron program, stating that it is the next major driver for the stock.

Rocket Lab Corporation (RKLB) Dips More Than Broader Market: What You Should Know

Rocket Lab Corporation (RKLB) reached $64.26 at the closing of the latest trading day, reflecting a -3.25% change compared to its last close.

Are You Looking for a Top Momentum Pick? Why Rocket Lab Corporation (RKLB) is a Great Choice

Does Rocket Lab Corporation (RKLB) have what it takes to be a top stock pick for momentum investors? Let's find out.

Rocket Lab Corporation (RKLB) Upgraded to Buy: Here's What You Should Know

Rocket Lab Corporation (RKLB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Rocket Lab Corp. (RKLB) announced on Friday that it has secured a pair of dedicated launch agreements with the Japan Aerospace Exploration Agency (JAXA), signaling continued international trust in its Electron launch vehicle for delivering satellites to orbit.&nbsp;The missions, both set to launch from Rocket Lab’s New Zealand-based Launch Complex 1, will support JAXA’s Satellite Technology Demonstration Program. The first launch, expected to occur in December 2025, will carry the agency’s RAISE-4 satellite into orbit to showcase eight experimental technologies from a mix of Japanese academic institutions and private-sector firms.&nbsp;After the announcement,&nbsp;<a href="https://stocktwits.com/symbol/RKLB">Rocket Lab stock&nbsp;</a>traded over 6% higher and was the second-most trending equity ticker on Stocktwits. Retail sentiment around the stock remained in ‘bullish’ territory amid ‘high’ message volume levels.&nbsp;Rocket Lab’s second launch for JAXA is slated for 2026 and will serve as a rideshare mission. That flight will carry a collection of eight payloads, including educational satellites, an ocean-monitoring system, and a technology demonstration of an origami-inspired deployable antenna capable of expanding 25-fold once in space.“Japanese satellite operators have long turned to Electron for its reliability and responsiveness since its earliest launches - whether its constellation-building for Japan’s new wave of commercial satellite operators, or bespoke missions requiring responsive mission planning and highly-accurate payload deployment,” said Rocket Lab founder and CEO, Sir Peter Beck.On Wednesday,&nbsp;the launch services provider also&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/why-is-rocket-lab-stock-gaining-3-premarket/ch6EffaR3Lm">signed</a> a multi-launch deal with the Institute for Q-shu Pioneers of Space.&nbsp;Rocket Lab stock&nbsp;has gained over 178% year-to-date and 656% in the last 12 months.&nbsp;Also See:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/astspacemobile-stock-hits-all-time-high-as-investor-interest-around-its-partnerships-surges/ch6aCgFR3St">AST SpaceMobile Stock Hits All-Time High As Investor Interest Around Its Partnerships Surges</a>For updates and corrections, email newsroom[at]stocktwits[dot]com.

In this photo illustration, the logo of Rocket Lab USA, Inc. is displayed on a smartphone screen.

Why Is Rocket Lab Stock Rising Today?

The missions, both set to launch from Rocket Lab’s New Zealand-based Launch Complex 1, will support JAXA’s Satellite Technology Demonstration Program. 

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Will Netflix ($NFLX) beat quarterly earnings? 
 
*Powered by Polymarket

Stocktwits

Netflix Inc

) beat quarterly earnings? 
 
*Powered by Polymarket

RKLB
Rocket Lab USA Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest RKLB News

RKLBRocket Lab USA Inc